Insider track record
OtherAcross 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Davis Andrew. Director active across 1 company, notably Ironwood Pharmaceuticals INC. In total, 9 reports have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €439k. History available since 21 November 2022. The latest transaction was disclosed on 18 November 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
5,360 shares@ US$4.084.7% of flowClass A Common StockSEC:0000950170-24-129228:0
22,725 shares@ US$6.4530.7% of flowClass A Common StockSEC:0000950170-24-063482:0
37,120 shares0Class A Common StockSEC:0000950170-24-029910:0
9,846 shares@ US$15.2431.6% of flowClass A Common StockSEC:0000950170-24-015548:0
3,287 shares@ US$9.696.6% of flowClass A Common StockSEC:0001209191-23-056446:0
6,305 shares@ US$10.1213.4% of flowClass A Common StockSEC:0001209191-23-031873:0
74,236 shares0Class A Common StockSEC:0001209191-23-017873:0
1,751 shares@ US$11.414.3% of flowClass A Common StockSEC:0001209191-23-014276:0
3,335 shares@ US$11.568.5% of flowClass A Common StockSEC:0001209191-22-058607:0